144 related articles for article (PubMed ID: 36273237)
21. Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacity.
Li S; Yue D; Chen X; Wang L; Li J; Ping Y; Gao Q; Wang D; Zhang T; Li F; Yang L; Huang L; Zhang Y
Oncol Rep; 2015 Jan; 33(1):425-32. PubMed ID: 25351876
[TBL] [Abstract][Full Text] [Related]
22. A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.
Liu S; Sun X; Wang M; Hou Y; Zhan Y; Jiang Y; Liu Z; Cao X; Chen P; Liu Z; Chen X; Tao Y; Xu C; Mao J; Cheng C; Li C; Hu Y; Wang L; Chin YE; Shi Y; Siebenlist U; Zhang X
Gastroenterology; 2014 Oct; 147(4):847-859.e11. PubMed ID: 24931456
[TBL] [Abstract][Full Text] [Related]
23. A proximal kappaB site in the IL-23 p19 promoter is responsible for RelA- and c-Rel-dependent transcription.
Mise-Omata S; Kuroda E; Niikura J; Yamashita U; Obata Y; Doi TS
J Immunol; 2007 Nov; 179(10):6596-603. PubMed ID: 17982049
[TBL] [Abstract][Full Text] [Related]
24. Relevance of Neurotrophin Receptors CD271 and TrkC for Prognosis, Migration, and Proliferation in Head and Neck Squamous Cell Carcinoma.
Foerster Y; Stöver T; Wagenblast J; Diensthuber M; Balster S; Gabrielpillai J; Petzold H; Geissler C
Cells; 2019 Sep; 8(10):. PubMed ID: 31569361
[TBL] [Abstract][Full Text] [Related]
25. N-tosyl-L-phenylalanine chloromethyl ketone inhibits NF-kappaB activation by blocking specific cysteine residues of IkappaB kinase beta and p65/RelA.
Ha KH; Byun MS; Choi J; Jeong J; Lee KJ; Jue DM
Biochemistry; 2009 Aug; 48(30):7271-8. PubMed ID: 19591457
[TBL] [Abstract][Full Text] [Related]
26. Biliary reflux as a causal factor in hypopharyngeal carcinoma: New clinical evidence and implications.
Sasaki CT; Doukas SG; Costa J; Vageli DP
Cancer; 2019 Oct; 125(20):3554-3565. PubMed ID: 31310330
[TBL] [Abstract][Full Text] [Related]
27. PPM1A is a RelA phosphatase with tumor suppressor-like activity.
Lu X; An H; Jin R; Zou M; Guo Y; Su PF; Liu D; Shyr Y; Yarbrough WG
Oncogene; 2014 May; 33(22):2918-27. PubMed ID: 23812431
[TBL] [Abstract][Full Text] [Related]
28. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
Kim DW; Gazourian L; Quadri SA; Romieu-Mourez R; Sherr DH; Sonenshein GE
Oncogene; 2000 Nov; 19(48):5498-506. PubMed ID: 11114727
[TBL] [Abstract][Full Text] [Related]
29. Role of Ca2+/calmodulin-dependent kinase II-IRAK1 interaction in LMP1-induced NF-κB activation.
Kim JE; Kim SY; Lim SY; Kieff E; Song YJ
Mol Cell Biol; 2014 Feb; 34(3):325-34. PubMed ID: 24248603
[TBL] [Abstract][Full Text] [Related]
30. Binding loci of RelA-containing nuclear factor-kappaB dimers in promoter regions of PHM1-31 myometrial smooth muscle cells.
Cookson VJ; Waite SL; Heath PR; Hurd PJ; Gandhi SV; Chapman NR
Mol Hum Reprod; 2015 Nov; 21(11):865-83. PubMed ID: 26405173
[TBL] [Abstract][Full Text] [Related]
31. In vitro model for gastroduodenal reflux-induced nuclear factor-kappaB activation and its role in hypopharyngeal carcinogenesis.
Sasaki CT; Issaeva N; Vageli DP
Head Neck; 2016 Apr; 38 Suppl 1():E1381-91. PubMed ID: 26559497
[TBL] [Abstract][Full Text] [Related]
32. RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow.
Xu J; Zhou P; Wang W; Sun A; Guo F
J Mol Med (Berl); 2014 Jan; 92(1):77-92. PubMed ID: 24042463
[TBL] [Abstract][Full Text] [Related]
33. Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit.
Yang XD; Huang B; Li M; Lamb A; Kelleher NL; Chen LF
EMBO J; 2009 Apr; 28(8):1055-66. PubMed ID: 19262565
[TBL] [Abstract][Full Text] [Related]
34. BRCA1 augments transcription by the NF-kappaB transcription factor by binding to the Rel domain of the p65/RelA subunit.
Benezra M; Chevallier N; Morrison DJ; MacLachlan TK; El-Deiry WS; Licht JD
J Biol Chem; 2003 Jul; 278(29):26333-41. PubMed ID: 12700228
[TBL] [Abstract][Full Text] [Related]
35. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor α induces epithelial-mesenchymal transition and promotes metastasis via NF-κB signaling pathway-mediated TWIST expression in hypopharyngeal cancer.
Yu L; Mu Y; Sa N; Wang H; Xu W
Oncol Rep; 2014 Jan; 31(1):321-7. PubMed ID: 24220622
[TBL] [Abstract][Full Text] [Related]
37. MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells.
Mori Y; Akita K; Tanida S; Ishida A; Toda M; Inoue M; Yashiro M; Sawada T; Hirakawa K; Nakada H
J Biol Chem; 2014 Dec; 289(51):35193-204. PubMed ID: 25371209
[TBL] [Abstract][Full Text] [Related]
38. Disruption of asymmetric dimethylarginine-induced RelA/P65 association with actin in endothelial cells.
Guo W; Zhang D; Wang L; Zhang Y; Liu W
Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):229-35. PubMed ID: 23296075
[TBL] [Abstract][Full Text] [Related]
39. Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis.
Bassères DS; Ebbs A; Levantini E; Baldwin AS
Cancer Res; 2010 May; 70(9):3537-46. PubMed ID: 20406971
[TBL] [Abstract][Full Text] [Related]
40. NF-kappaB signalling proteins p50/p105, p52/p100, RelA, and IKKepsilon are over-expressed in oesophageal squamous cell carcinomas.
Kang MR; Kim MS; Kim SS; Ahn CH; Yoo NJ; Lee SH
Pathology; 2009; 41(7):622-5. PubMed ID: 20001340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
